Euroapi's earnings have been declining at an average annual rate of -51.8%, while the Pharmaceuticals industry saw earnings growing at 9.4% annually. Revenues have been declining at an average rate of 1.4% per year.
Key information
-51.85%
Earnings growth rate
-51.71%
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
-1.40%
Return on equity
-26.80%
Net Margin
-24.77%
Next Earnings Update
28 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Euroapi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:EAPI.F Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
853
-211
119
27
30 Sep 25
868
-168
120
25
30 Jun 25
883
-124
121
22
31 Mar 25
901
-127
125
24
31 Dec 24
919
-131
130
26
30 Sep 24
945
-209
132
28
30 Jun 24
971
-287
135
30
31 Mar 24
995
-238
134
30
31 Dec 23
1,019
-190
134
30
30 Sep 23
1,006
-79
135
27
30 Jun 23
994
31
137
24
31 Mar 23
987
8
133
23
31 Dec 22
981
-15
129
22
30 Sep 22
962
-3
120
20
30 Jun 22
944
10
110
18
31 Mar 22
918
1
100
18
31 Dec 21
893
-8
90
17
31 Dec 20
945
-6
71
20
31 Dec 19
916
3
66
16
Quality Earnings: EAPI.F is currently unprofitable.
Growing Profit Margin: EAPI.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EAPI.F is unprofitable, and losses have increased over the past 5 years at a rate of 51.8% per year.
Accelerating Growth: Unable to compare EAPI.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EAPI.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-4.8%).
Return on Equity
High ROE: EAPI.F has a negative Return on Equity (-26.8%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/15 14:36
End of Day Share Price
2026/06/15 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Euroapi S.A. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.